ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2019

TLR1/2 Specific Small-Molecule Agonist Suppresses Leukemia Cancer Cell Growth by Stimulating Cytotoxic T Lymphocytes.

Xiaohong Cen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.